Study reveals a biological link between stress and obesity

September 21, 2016, Hebrew University of Jerusalem
Laurel and Hardy and the microRNA connection – it's not coincidental that the heavier character is also the most anxious of the duo. Credit: Petra Pollins

Metabolic and anxiety-related disorders both pose a significant healthcare burden, and are in the spotlight of contemporary research and therapeutic efforts. Although intuitively we assume that these two phenomena overlap, the link has not been proven scientifically.

Now, a team of researchers from the Hebrew University of Jerusalem, headed by Prof. Hermona Soreq from the Edmond and Lily Safra Center for Brain Sciences, revealed the molecular elements that bridge anxiety and metabolism – a type of microRNA that influences shared biological mechanisms.

"We already know that there is a connection between body and mind, between the physical and the emotional, and studies show that psychological trauma affects the activity of many genes. Our previous research found a link between microRNA and - stress and anxiety generate an inflammatory response and dramatically increase the expression levels of microRNA regulators of inflammation in both the brain and the gut, for example the situation of patients with Crohn's disease may get worse under psychological stress," says Prof. Soreq.

"In the present study, we added obesity to the equation. We revealed that some anxiety-induced microRNA are not only capable of suppressing inflammation but can also potentiate metabolic syndrome-related processes. We also found that their expression level is different in diverse tissues and cells, depending on heredity and exposure to stressful situations," explains Prof. Soreq.

The family of microRNA genes is part of the human genome, which was considered until not too long ago as "junk-DNA". However, microRNAs are now known to fulfill an important role in regulating the production process of proteins by other genes. These tiny RNA molecules, which are one percent of the average size of a protein-coding gene, act as suppressors of inflammation and are able to halt the production of proteins.

The research paper, published in the journal Trends in Molecular Medicine, details the evidence linking microRNA pathways, which share regulatory networks in metabolic and anxiety-related conditions. In particular, microRNAs involved in these disorders include regulators of acetylcholine signaling in the nervous system and their accompanying molecular machinery.

Metabolic disorders, such as abdominal obesity and diabetes, have become a global epidemic. In the USA, the prevalence of metabolic syndrome is as high as 35 percent. In other countries, such as Austria, Denmark and Ireland it affects 20-25 percent of the population.

Anxiety disorders are harder to quantify than metabolic ones. They include obsessive-compulsive disorder (OCD), (PTSD) and phobia. The full burden of the anxiety spectrum is difficult to assess, due to under-diagnosis and poorly defined pathophysiological processes.

This newly revealed link offers novel opportunities for innovative diagnoses and treatment of both metabolic and anxiety-related phenomena.

"The discovery has a diagnostic value and practical implications, because the activity of microRNAs can be manipulated by DNA-based drugs," explains Prof. Soreq. "It also offers an opportunity to reclassify 'healthy' and 'unhealthy' anxiety and metabolic-prone states, and inform putative strategies to treat these disorders."

Explore further: Study links autism to changes in micro-RNAs

More information: Chanan Meydan et al, MicroRNA Regulators of Anxiety and Metabolic Disorders, Trends in Molecular Medicine (2016). DOI: 10.1016/j.molmed.2016.07.001

Related Stories

Study links autism to changes in micro-RNAs

September 1, 2016
In an important new study, scientists at UCLA have found that the brains of people with autism spectrum disorders show distinctive changes in the levels of tiny regulator molecules known as microRNAs, which control the activities ...

New study finds connection between chronic pain and anxiety disorders

August 31, 2016
New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment. The study's findings, published as an Article in Press in ...

PTSD increases risk for metabolic syndrome and reduced cortical thickness

August 31, 2016
Metabolic syndrome, a cluster of cardiometabolic conditions, may be a biological mechanism linking posttraumatic stress disorder (PTSD) to structural brain abnormalities, according to a new study in Biological Psychiatry. ...

Overexpression of corticotropin-releasing factor increases anxiety in primates

September 6, 2016
A new study in Biological Psychiatry reports that overexpression of corticotropin-releasing factor (CRF), a stress-related gene, increases anxious temperament in monkeys. According to Ned Kalin from the University of Wisconsin-Madison ...

Gastrointestinal disorders involve both brain-to-gut and gut-to-brain pathways

July 22, 2016
New research indicates that in patients with irritable bowel syndrome (IBS) or indigestion, there is a distinct brain-to-gut pathway, where psychological symptoms begin first, and separately a distinct gut-to-brain pathway, ...

Review links anxiety disorders to risk of cardiovascular events

August 15, 2016
(HealthDay)—Anxiety disorders are associated with a range of cardiovascular events, according to a meta-analysis published in the Aug. 15 issue of The American Journal of Cardiology.

Recommended for you

Internet therapy apps reduce depression symptoms, study finds

December 7, 2018
In a sweeping new study, Indiana University psychologists have found that a series of self-guided, internet-based therapy platforms effectively reduce depression.

Gender bias sways how we perceive competence in faces

December 7, 2018
Faces that are seen as competent are also perceived as more masculine, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Targeted cognitive training benefits patients with severe schizophrenia

December 7, 2018
Schizophrenia is among the most difficult mental illnesses to treat, in part because it is characterized by a wide range of dysfunction, from hallucinations and mood disorders to cognitive impairment, especially verbal and ...

Pot withdrawal eased for dependent users

December 6, 2018
A new drug can help people diagnosed with cannabis use disorder reduce withdrawal symptoms and marijuana use, a new Yale-led study published Dec. 6 in the journal Lancet Psychiatry shows.

Link between neonatal vitamin D deficiency and schizophrenia confirmed

December 6, 2018
Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported.

Alterations in brain networks explain why some children are resilient to maltreatment

December 6, 2018
People who experience childhood maltreatment frequently have perturbations in their brain architecture, regardless of whether they develop psychiatric symptoms, but a study in Biological Psychiatry found additional alterations ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.